Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Investigational New Drugs|July 18, 2016
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumorsLee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.
Chembiochem : a European Journal of Chemical Biology|August 11, 2018
Crystal Structure of PigA: A Prolyl Thioester-Oxidizing Enzyme in Prodigiosin BiosynthesisCheng-Chung Lee, Tzu-Ping Ko, Chun-Ting Chen, et al.
Arthritis and Rheumatism|December 30, 2009
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trialJoan T Merrill, C Michael Neuwelt, Daniel J Wallace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaRanjana H Advani, Daniel Lebovic, Andy Chen, et al.
Investigational New Drugs|April 26, 2019
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumorsGeoffrey I Shapiro, Patricia LoRusso, Eunice Kwak, et al.
Genetic Epidemiology|November 30, 2007
Summary of contributions to GAW15 Group 13: candidate gene association studiesMariza de Andrade, Andrew S Allen, Dimitru Brinza, et al.
Pageof 3